Compare Stocks → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:GSDCVE:KNENYSE:NFXCVE:PAS Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGSDGlobal System Dynamics$11.11$11.16$9.90▼$11.98$36.77MN/A7,280 shs2 shsKNEKane BiotechC$0.10C$0.10C$0.05▼C$0.14C$13.18M0.5659,912 shs143,500 shsNFXNewfield Exploration$17.07$0.00$12.45▼$31.46$3.43B1.858.80 million shsN/APASPascal BiosciencesC$0.02-25.0%C$0.02C$0.02▼C$0.10C$984K1.5152,289 shs4,000 shs7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGSDGlobal System Dynamics0.00%0.00%0.00%+0.54%+5.81%KNEKane Biotech0.00%0.00%-4.76%+25.00%-13.04%NFXNewfield Exploration0.00%0.00%0.00%0.00%0.00%PASPascal Biosciences0.00%0.00%0.00%0.00%0.00%This consistently signaled gains of 453%... 610%... and even 1036%... (Ad)It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGSDGlobal System DynamicsN/AN/AN/AN/AN/AN/AN/AN/AKNEKane BiotechN/AN/AN/AN/AN/AN/AN/AN/ANFXNewfield ExplorationN/AN/AN/AN/AN/AN/AN/AN/APASPascal BiosciencesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGSDGlobal System DynamicsN/AN/AN/AN/AKNEKane BiotechN/AN/AN/AN/ANFXNewfield ExplorationN/AN/AN/AN/APASPascal BiosciencesN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGSDGlobal System DynamicsN/AN/AN/AN/A($1.84) per shareN/AKNEKane BiotechC$2.74M4.81C$0.01 per share8.50C($0.07) per share-1.43NFXNewfield Exploration$1.77B1.94$4.50 per share3.79$7.05 per share2.42PASPascal BiosciencesN/AN/AC$0.00 per share55.00C($0.02) per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGSDGlobal System Dynamics-$790KN/A0.00∞N/AN/AN/A-2.30%N/AKNEKane Biotech-C$4.32M-C$0.03N/A∞N/A-157.48%N/A-32.70%5/23/2024 (Estimated)NFXNewfield Exploration$427M$2.157.945.170.3721.14%43.65%13.21%N/APASPascal BiosciencesN/A-C$0.01N/A∞N/AN/AN/A-340.40%N/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGSDGlobal System DynamicsN/AN/AN/AN/AN/AKNEKane BiotechN/AN/AN/AN/AN/ANFXNewfield ExplorationN/AN/AN/AN/AN/APASPascal BiosciencesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGSDGlobal System DynamicsN/A0.010.01KNEKane Biotech1,164.240.370.39NFXNewfield Exploration1.300.720.70PASPascal Biosciences882.790.030.17OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGSDGlobal System Dynamics24.82%KNEKane BiotechN/ANFXNewfield Exploration97.87%PASPascal BiosciencesN/AInsider OwnershipCompanyInsider OwnershipGSDGlobal System Dynamics62.81%KNEKane Biotech36.45%NFXNewfield Exploration0.59%PASPascal Biosciences15.43%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableGSDGlobal System DynamicsN/A3.31 million1.23 millionNot OptionableKNEKane BiotechN/A131.84 millionN/ANot OptionableNFXNewfield ExplorationN/A200.93 millionN/AOptionablePASPascal Biosciences665.59 millionN/ANot OptionableGSD, KNE, RLM, NFX, and PAS HeadlinesSourceHeadlineFans incredibly worried over claim Pedro Pascal is already finished shooting The Last of Us season 2unilad.com - March 29 at 8:47 AMPascal Siakam Player Prop Bets: Pacers vs. Lakers | March 29sportsbookwire.usatoday.com - March 29 at 8:47 AMPascal Siakam NBA Player Preview vs. the Lakers - March 29wave3.com - March 29 at 8:47 AMJohn Davidson Gives An Update On GM Search, Pascal Vincentmsn.com - March 28 at 8:04 PMPedro Pascal Wraps 'The Last Of Us' Season 2 Filming In Record Time: What It Means For Joel's Fatemsn.com - March 27 at 7:48 PMThe Last Of Us 2 Fans Mock Pedro Pascal's Short Filming Stint On Season 2msn.com - March 27 at 2:48 PMPascal Struijk: Leeds United defender out for season after groin surgerybbc.co.uk - March 27 at 2:48 PMThe Last of Us Season 2 gets surprising Pedro Pascal updatemsn.com - March 27 at 2:48 PMPacers forward Pascal Siakam nominated for Eastern Conference Player of the Week againathlonsports.com - March 27 at 9:48 AMBulls aiming to contain Pacers' red-hot Pascal Siakamcbssports.com - March 27 at 9:48 AMHBO denies rumors that Pedro Pascal has finished filming Season 2 of «The Last of Us»itc.ua - March 27 at 9:48 AMThe Last Of Us Fans Fear The Worst After Pedro Pascal Filming Update, But I Have A More Optimistic Theorymsn.com - March 27 at 9:48 AMWhy Pedro Pascal's The Last of Us Schedule Became a Major Storymsn.com - March 27 at 9:48 AMPascal Siakam NBA Player Preview vs. the Bulls - March 2714news.com - March 27 at 9:48 AMPascal Siakam discusses his 31-point effort and the Pacers win over the Clippers.indystar.com - March 26 at 9:50 AMThe Last of Us fans fear the worst as Pedro Pascal wraps filming for Season 2dexerto.com - March 26 at 4:50 AMPascal Siakam helps Pacers pull away from Clippers for 133-116 winmsn.com - March 26 at 4:50 AMLeeds United reach Pascal Struijk surgery deadline as potential season-ending decision set for revealmsn.com - March 25 at 6:48 PMPascal Siakam Player Prop Bets: Pacers vs. Clippers | March 25sportsbookwire.usatoday.com - March 25 at 6:48 PMPascal Siakam NBA Player Preview vs. the Clippers - March 25wkyt.com - March 25 at 6:48 PMPacers forward Pascal Siakam discusses his 36-point effort in a loss to Los Angeles.indystar.com - March 25 at 9:03 AMOne Star Wars Scene Is Pedro Pascal’s Best In The Mandalorian – Can It Ever Be Equalled?thetechedvocate.org - March 25 at 9:03 AMPascal Amanfo ties the knot, shares stunning photosmyjoyonline.com - March 25 at 9:03 AMPascal Siakam's 36-point paint domination shows how he's changed the Pacers' approachmsn.com - March 25 at 9:03 AMMedia Sentiment Over TimeTop HeadlinesHow to Invest in Artificial Intelligence in These Simple WaysMarch 7, 2024 1:08 PMView How to Invest in Artificial Intelligence in These Simple Ways5 Under-the-Radar Artificial Intelligence (AI) Stocks March 4, 2024 9:30 AMView 5 Under-the-Radar Artificial Intelligence (AI) Stocks Your Comprehensive Guide to Investing in Bank StocksMarch 1, 2024 10:41 AMView Your Comprehensive Guide to Investing in Bank StocksZscaler Stock Price Plunges: Buy the Dip Candidate March 1, 2024 9:05 AMView Zscaler Stock Price Plunges: Buy the Dip Candidate Is Ollies Bargain Outlet a Smart Buy-On Post-Release Weakness?March 20, 2024 10:46 AMView Is Ollies Bargain Outlet a Smart Buy-On Post-Release Weakness?All Headlines Company DescriptionsGlobal System DynamicsNASDAQ:GSDGlobal System Dynamics, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company focuses its search on the farming and national security sectors, including farming related operations and businesses that support the farming industry. The company was formerly known as Gladstone Acquisition Corporation. Global System Dynamics, Inc. was incorporated in 2021 and is based in Houston, Texas.Kane BiotechCVE:KNEKane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; and animal and human wound care solutions under the DispersinB name. It also offers scalp care products under the DermaKB brand name; and wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, Aledex, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.Newfield ExplorationNYSE:NFXNewfield Exploration Company, an independent energy company, engages in the exploration, development, and production of crude oil, natural gas, and natural gas liquids in the United States. The company has operations principally in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota, and the Uinta Basin of Utah. It also holds oil producing assets offshore China. The company was founded in 1988 and is headquartered in The Woodlands, Texas.Pascal BiosciencesCVE:PASPascal Biosciences Inc., a biotechnology company, engages in the research and development of products for the treatment of cancer, and for the improvement of the immune system. The company's development portfolio includes PAS-403, a mitosis inhibitor that blocks cell division for the treatment of glioblastoma and brain metastases originating from other cancers; and PAS-393, an immune-stimulatory cannabinoid designed to restore the immunogenicity of tumor cells with checkpoint inhibitor therapy for use in cancer treatment. It is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas; and cannabinoid therapeutic products for the treatment of COVID-19. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was incorporated in 2011 and is headquartered in Seattle, Washington. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.